Abstracts Archive - Page 37 of 1683 - ATC Abstracts

2022 American Transplant Congress
Pericardial Effusion: A Potential Late Complication of COVID-19 Infection
O. Sogbein, A. Rizvi, M. Mujtaba, S. Hussain
Internal Medicine, Division of Nephrology, University of Texas Medical Branch, Galveston, TX
*Purpose: COVID-19 infection involves entry of SARS-CoV-2 virus into cells via interaction between its spike protein and angiotensin converting enzyme resulting in an NF-κβ mediated…
2022 American Transplant Congress
Longevity Matching for Living Donor Renal Transplantation
S. Karhadkar¹, J. Dawes¹, K. Wirshup¹, J. Kolansky¹, A. Gregor¹, A. Diamond², A. DiCarlo¹
¹Temple University Hospital, Philadelphia, PA, ²-, Garnet Valley, PA
*Purpose: Living donor kidney transplantation (LDKT) continues to become a more prevalent treatment method for ESRD and is known to increase both organ availability and…
2022 American Transplant Congress
Cardiac Catheterization in ESKD Patients with High Cardiovascular Risk Prior to Kidney Transplantation
L. Morena¹, A. Al Jurdi², M. S. Bittencourt³, A. C. Bucay², N. Elias¹, R. Palsson², L. V. Riella¹
¹Transplant Surgery, Massachusetts General Hospital - Harvard Medical School, Boston, MA, ²Transplant Nephrology, Massachusetts General Hospital - Harvard Medical School, Boston, MA, ³Cardiac Imaging, Cardiology, University of Pittsburgh, Pittsburgh, PA
*Purpose: Cardiovascular disease is the leading cause of death after kidney transplantation (KT), with a high risk of myocardial infarction (MI) in the peri-transplantation period.…
2022 American Transplant Congress
Physiological Age by Artificial Intelligence-Enhanced Electrograms as a Novel Biomarker of Mortality in Kidney Transplant Candidates
E. Lorenz, I. Zaniletti, B. Johnson, T. Petterson, W. Kremers, C. Schinstock, H. Amer, A. Cheville, N. LeBrasseur, A. Baez-Suarez, Z. Attia, F. Lopez-Jimenez, P. Friedman, C. Kennedy, A. Rule
Mayo Clinic, Rochester, MN
*Purpose: Assessing mortality risk prior to kidney transplantation is challenging. Age-Gap, which is the difference between physiological age determined by artificial intelligence-enhanced electrocardiograms (ECG) and…
2022 American Transplant Congress
Changes in Cold Ischemia Time and Transplantation Practices with the Concentric Model of Kidney Allocation
C. M. Puttarajappa¹, P. Sood¹, A. Tevar¹, V. Gunabushanam¹, S. Hariharan¹, S. Mohan²
¹University of Pittsburgh Medical Center, Pittsburgh, PA, ²Columbia University, New York, NY
*Purpose: Evaluate impact of the new concentric kidney allocation system (KAS250) on kidney utilization, allocation practices and cold ischemia time (CIT).*Methods: Using data from the…
2022 American Transplant Congress
“ABO-Adjusted CPRA”: A Unified Metric for Immunologic Compatibility in Kidney Transplantation
L. Gragert¹, M. Kadatz², J. Alcorn³, D. Stewart³, D. Chang², J. Gill², R. Liwski⁴, H. Gebel⁵, E. Kransdorf⁶, J. Gill², J. Lan²
¹Tulane University, New Orleans, LA, ²University of British Columbia, Vancouver, BC, Canada, ³UNOS, Richmond, VA, ⁴Dalhousie University, Halifax, NS, Canada, ⁵Emory University, Atlanta, GA, ⁶Cedars-Sinai, Beverly Hills, CA
*Purpose: Implementation of the kidney allocation system in 2014 greatly reduced access disparity due to HLA sensitization. To address persistent disparities among both candidate cPRA…
2022 American Transplant Congress
Low-Dose Aspirin is Effective in Preventing Transplant Renal Artery Stenosis: A Prospective Randomized Controlled Trial
X. Tian, W. Duan, X. Niu, X. Wu, C. Zhang, J. Zhao, Z. Wang, G. Cao, B. Ji, Y. Gu, H. Cao, T. Qin, F. Shao, T. Yan
Henan Provincial People's Hospital, Zhengzhou, Henan Province, China
*Purpose: Transplant renal artery stenosis (TRAS), the most common post-transplant vascular complication, leads to resistant hypertension, renal impairment, and even graft loss. No effective prophylactic…
2022 American Transplant Congress
Outcomes After Deceased Donor Kidney Transplantation Utilizing Kidney Allografts with Marginal Perfusion Parameters: A Single-Center Experience
P. N. Chotai¹, A. Logan², F. Siddiqui³, A. Schenk⁴, G. Bumgardner⁵, G. L. Brock², A. El-Hinnawi⁵, A. Rajab⁶, K. Washburn⁷, N. Singh²
¹Division of Transplantation, Department of General Surgery, The Ohio State University Wexner Medical Center, Columbus, OH, ²The Ohio State University Wexner Medical Center, Columbus, OH, ³Ohio State University, Bloomfield, NJ, ⁴Ohio State University Wexner Medical Center, Bexley, OH, ⁵Ohio State University, Columbus, OH, ⁶Ohio State University Wexner Medical Center, Columbus, OH, ⁷The Ohio State University, Columbus, OH
*Purpose: To study outcomes of deceased donor kidney transplantation (DDKT) in recipients of kidney allografts with poor perfusion parameters.*Methods: This is a retrospective, single center…
2022 American Transplant Congress
Donor Terminal Creatinine – Does It Matter?
V. G. Menon, Y. Wert, W. Hoffman, D. Ladie, M. Singh, M. Waybill, H. Yang
UPMC, Harrisburg, PA
*Purpose: When assessing deceased donor kidneys, the transplantation team studies several donor variables including creatinine. A creatinine that is elevated immediately prior to procurement can…
2022 American Transplant Congress
Semaglutide Tolerability and Efficacy in Patients with Chronic Kidney Disease Stage 4, 5 and End Stage Renal Disease
J. J. Long, A. Lemke, V. Sudhindran, N. Pencovici, A. Kukla, T. Diwan
Mayo Clinic, Rochester, MN
*Purpose: Obesity is often a barrier to kidney transplantation (KT) due to increased perioperative risks and worse outcomes with many transplant centers setting BMI cut…